Serotonin 5-HT1A receptors might control the output of cortical glutamatergic neurons in rat cingulate cortex

被引:72
作者
Czyrak, A [1 ]
Czepiel, K [1 ]
Mackowiak, M [1 ]
Chocyk, A [1 ]
Wedzony, KW [1 ]
机构
[1] Polish Acad Sci, Inst Pharmacol, Lab Pharmacol & Brain Biostruct, PL-31343 Krakow, Poland
关键词
5-HT1A receptor; neurofilament H; parvalbumin; glutamate; double labeling; immunohistochemistry;
D O I
10.1016/S0006-8993(03)03352-3
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The present study was designed to investigate the distribution of serotonin 5-HT1A receptor protein (5-HT1A-immunoreactivity) and it, localization within cortical pyramidal neurons of the rat cingulate cortex. This experimental direction was inspired by recent data showing the role of 5-HT1A receptors in the pathology of schizophrenia, and in the mechanism of action of novel antipsychotic drugs as well as by the importance of the cingulate cortex in regulation of cognitive functions. It was found that 5-HT1A-immunoreactivity was densely distributed in neuronal eyelash-like elements, and their size, shape and spatial orientation may suggest concentration of 5-HT1A-immunopositive material in the proximal fragments of axons of cortical neurons. Moreover, it was observed that these 5-HT1A-immunopositive fragments were present predominately on proximal fragments of axons of pyramidal neurons, which was evidenced by double labeling experiments using glutamate and non-phosphorylated neurofilament H as markers of the cortical pyramidal cells. The 5-HT1A receptor immunoreactivity was localized distally to the inhibitory GABAergic terminals of chandelier and basket cells surrounding the pyramidal cell bodies and occasionally surrounding short initial segment of axonal hillock of pyramidal neurons. These anatomical data indicate that 5-HT1A receptors might control the excitability and propagation of information transmitted by the pyramidal cells. Moreover, our results indicate that drugs operating via 5-HT1A receptors in the cingulate cortex might control from this level the release of glutamate in the subcortical structures. Finally, the 5-HT1A receptors present in the cingulate cortex, as demonstrated in the present study, may constitute an important target for drugs used to repair dysfunction of glutamate neurotransmission, which is observed for example in schizophrenia. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:42 / 51
页数:10
相关论文
共 74 条
[1]   Experimental investigations for the mariculture of Gracilaria in Saldanha Bay, South Africa [J].
Anderson, RJ ;
Levitt, GJ ;
Share, A .
JOURNAL OF APPLIED PHYCOLOGY, 1996, 8 (4-5) :421-430
[2]  
[Anonymous], RAT BRAIN STEREOTAXI
[3]   Molecular characterization of antipeptide antibodies against the 5-HT1A receptor: evidence for state-dependent antibody binding [J].
Anthony, TE ;
Azmitia, EC .
MOLECULAR BRAIN RESEARCH, 1997, 50 (1-2) :277-284
[4]   (R)-8-OH-DPAT PREFERENTIALLY INCREASES DOPAMINE RELEASE IN RAT MEDIAL PREFRONTAL CORTEX [J].
ARBORELIUS, L ;
NOMIKOS, GG ;
HACKSELL, U ;
SVENSSON, TH .
ACTA PHYSIOLOGICA SCANDINAVICA, 1993, 148 (04) :465-466
[5]   Cellular localization of the 5-HT1A receptor in primate brain neurons and glial cells [J].
Azmitia, EC ;
Gannon, PJ ;
Kheck, NM ;
WhitakerAzmitia, PM .
NEUROPSYCHOPHARMACOLOGY, 1996, 14 (01) :35-46
[6]   ANTIPEPTIDE ANTIBODIES AGAINST THE 5-HT1A RECEPTOR [J].
AZMITIA, EC ;
YU, I ;
AKBARI, HM ;
KHECK, N ;
WHITAKERAZMITIA, PM ;
MARSHAK, DR .
JOURNAL OF CHEMICAL NEUROANATOMY, 1992, 5 (04) :289-298
[7]   The 5-HT1A receptor in schizophrenia:: a promising target for novel atypical neuroleptics? [J].
Bantick, RA ;
Deakin, JFW ;
Grasby, PM .
JOURNAL OF PSYCHOPHARMACOLOGY, 2001, 15 (01) :37-46
[8]   A review of central 5-HT receptors and their function [J].
Barnes, NM ;
Sharp, T .
NEUROPHARMACOLOGY, 1999, 38 (08) :1083-1152
[9]   GABAergic interneurons: Implications for understanding schizophrenia and bipolar disorder [J].
Benes, FM ;
Berretta, S .
NEUROPSYCHOPHARMACOLOGY, 2001, 25 (01) :1-27
[10]   Anatomical MRI study of subgenual prefrontal cortex in bipolar and unipolar subjects [J].
Brambilla, P ;
Nicoletti, MA ;
Harenski, K ;
Sassi, RB ;
Mallinger, AG ;
Frank, E ;
Kupfer, DJ ;
Keshavan, MS ;
Soares, JC .
NEUROPSYCHOPHARMACOLOGY, 2002, 27 (05) :792-799